Literature DB >> 32861386

Large arteriotomies closure using a combination of vascular closure devices during TEVAR/EVAR: A single centre experience.

Navjyot Kaur1, Bhupendra Kumar Sihag2, Prashant Panda1, Sanjeev Naganur1, Parag Barwad3.   

Abstract

In this case series, we share our experience of total percutaneous closure of large arteriotomies using combination of vascular closure devices (VCD). A total of six patients with seven sites for endovascular repair were taken for total percutaneous endovascular aortic repair. Ten femoral arteriotomies (26 French (F) = 2, 24 F = 1, 22 F = 3, 20 F = 1, 18 F = 1 &16 F = 2) were successfully closed with 26 Perclose™ and 07 Angio-seal™ devices. There were no local site complications or VCD failure in any of our patients.
Copyright © 2020 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hybrid; Large arteriotomies; Total PEVAR

Mesh:

Year:  2020        PMID: 32861386      PMCID: PMC7474102          DOI: 10.1016/j.ihj.2020.06.008

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


Introduction

Owing to lower immediate morbidity, mortality & comparable long-term results, endovascular aortic repair (EVAR) is now the standard of care for thoracic aortic aneurysms (TAA), abdominal aortic aneurysms (AAA) and complicated type B aortic dissections.1 The less invasive total percutaneous endovascular aorta repair (PEVAR) as we call it; when the arteriotomy is also closed percutaneously, reduces the procedural time, wound size, chances of wound infection and hospital stay., A recent review by National Surgical Quality Improvement Program revealed that more than half of EVARs are now being closed using total percutaneous technique., Data suggests that total PEVAR is preferable; however larger arteriotomies required in repair of thoracic aorta are still closed surgically. Largest arteriotomy which has been reported to be closed percutaneously using more than one Perclose™ is 22 French (F) whereas hybrid technique using one Perclose™ and one Angio-seal™ has been described in 19 F arteriotomy. We hereby present our experience of closing large arteriotomies (largest being 26 F) using combination of suture based (Perclose™) and collagen based (Angio-seal™) VCDs.

Methodology

We assessed a total of 06 consecutive patients who required aortic repair for total PEVAR. In addition to detailed pre-procedural evaluation of aortic pathology, we evaluated the bilateral femoral arteries (FA) for feasibility of total PEVAR using CT angiogram which included the size, anatomy and calcification of bilateral FA. Endovascular graft size dictated the sheath size required for procedure. If there was a discrepancy between the sizes of two FAs, the side with larger diameter was considered the primary access site and the other side was considered secondary site. In case the size of both FAs was comparable; right FA was preferred for primary access as per operator's comfort. The choice of anaesthesia (local or general) was decided depending upon anticipated duration and complexity of procedure.

Technique of placement of VCDs (Perclose™ and Angio-seal™)

All femoral punctures were done under fluoroscopic guidance. The puncture used for primary access was made after angiography from the contralateral side to ensure the site of arteriotomy above the bifurcation of FA (Video: 1, 2). Standard technique of deployment of VCDs as directed by the manufacturer was followed. For any access site requiring a sheath size more than 8.5 F, two Proglide Perclose™ (Abbot Vascular) were placed at 10o clock and 2o clock position, prior to placement of sheath. After completion of procedure, the effect of heparin was reversed with protamine and the access site was closed using preplaced Perclose™ sutures. If hemostasis was not achieved with two preplaced Perclose™ sutures, either one more Perclose™ was deployed at 12o clock position and/or additional Angio-seal™ (Terumo Interventional Systems) was used to achieve hemostasis. Supplementary video related to this article can be found at https://doi.org/10.1016/j.ihj.2020.06.008 The following are the supplementary data related to this article: Video 1Angiography from contralateral femoral puncture site. Video 2Fluoroscopy guided puncture.

Results

Six patients of aortic pathologies (AAA = 3, TAA & AAA = 1, Type B aortic dissection = 2) were taken for total PEVAR. Table 1 describes the detailed anatomy of aortic pathology and the access vessels. Ten femoral arteriotomies (26 F = 2, 24 F = 1, 22 F = 3, 20 F = 1, 18 F = 1 & 16 F = 2) were successfully closed with a total of 26 Perclose™ and 07 Angio-seal™ VCDs. More than two Perclose™ devices were used to close six groins while hybrid technique combining Angio-seal™ with Perclose™ was used in seven groins. Angio-seal™  was used with more than one Perclose™ system in all hybrid closures; in four groins it was used along with three Perclose™ devices. A third Perclose™ or Angio-seal™ were used if hemostasis was not achieved after deployment of two pre-placed Perclose™ devices.
Table 1

Anatomy of Aortic Pathology and Access vessels (CT Angiography).

Patient 1AAAPatient 2AAAPatient 3Type B Aortic DissectionPatient 4TAA & AAAPatient 5AAAPatient 6Type B Aortic Dissection
Right (mm)
CIA14.58.713 (TL)16.51012
EIA9.247.959.47.48.310.1
CFA106.838.68.28.38.4
Left (mm)
CIA12.48.134.6 (TL)13.97.011.1
EIA10.17.389.38.88.38.1
CFA8.746.728.57.97.697.9
Tortuosity of Access VesselsNILNILMildMildNILMild
Calcification of Access VesselsNILNILNILMildMildMild
Aortic PathologyAAAAvg Size: 63 mmAAAAvg size: 45 mmDissection of DTA after left SCAAorta size at proximal landing zone: 29–30 mmTAA & AAATAA avg size: 90–100 mmAAA avg size: 60–70 mmAAAAvg Size: 70 mmDissection of DTA after left SCAAorta size at proximal landing zone: 26–27 mm

AAA, Abdominal aortic aneurysm; Avg, Average; CFA, Common Femoral Artery; CIA, Common Iliac Artery; CT; Computed Tomography; DTA, Descending thoracic aorta; TAA, Thoracic aortic aneurysm; TL, True lumen; VA, Vertebral Artery.

Anatomy of Aortic Pathology and Access vessels (CT Angiography). AAA, Abdominal aortic aneurysm; Avg, Average; CFA, Common Femoral Artery; CIA, Common Iliac Artery; CT; Computed Tomography; DTA, Descending thoracic aorta; TAA, Thoracic aortic aneurysm; TL, True lumen; VA, Vertebral Artery. There were no local site complications, no device failure, nor was any surgical assistance required to close any of the access sites. Four out of six procedures were performed under local anaesthesia. There was one death; due to posterior circulation stroke in a patient with extended aneurysm involving thoracic and abdominal aorta after 7 days of procedure but not related to access site complication. The rest five patients have been asymptomatic with normal Doppler studies of lower limb vessels. The last patient intervened has completed six months of follow up. The procedural details of total PEVAR in 06 patients and 10 sites have been summarized in Table 2.
Table 2

Procedural details of total percutaneous endovascular aorta repair (PEVAR).

S. NoRight FA sheath sizeLeft FA sheath sizeSite of interventionTotal number of grafts placedSize of graft and site of graftAnesthesiaDevice for Right FA repairDevice for Left FA repairComplications if any
Patient122 F18 FAAA1 main graft from Right FA.1 accessory limb from Left FA.Main limb: 25 × 16 × 166 mmAccessory limb: 16 × 16 × 124 mmGA3 Perclose2 Perclose and 1 AngiosealNone
Patient 222 F16 FAAA extending to iliac1 main graft from Right FA.1 accessory limb from Left FA.Main limb: 25 × 13 × 166 mmAccessory limb: 16 × 20 × 124LA3 Perclose2 PercloseNone
Patient 326 F7 FDissection of DTA after left SCA1 graft for Thoracic aorta.36 × 32 × 150 mmLA3 Perclose and 1 AngiosealLocal site manual compressionNone
Patient 426 F20 FTAA & AAA3 grafts for DTA and 2 grafts for AAA.Thoracic grafts: 40 × 40 × 200 mm, 40 × 36 × 150 mm, 42 × 38 × 150mmAbdominal graftsMain limb: 28 × 16 × 145 mm Accessory limb: 16 × 16 × 124 mmGA3 Perclose and 1 Angioseal3 Perclose and 1 AngiosealVA stroke 08 h after procedureDeath on day 8 of procedure due to secondary complications of stroke
Patient 522 F16 FAAA extending to iliacs1 main graft from Right FA and 1 accessory limb from Left FA.Main limb: 32 × 16 × 166 mm Accessory limb: 16 × 13 × 124mmLA3 Perclose and 1 Angioseal2 Perclose and 1 AngiosealNone
Patient 624 F6 FDissection of DTA just proximal to left SCA1graft for Thoracic aorta.36 × 32 × 150 mmLA2 Perclose and 1 AngiosealLocal site compressionNone

AAA, Abdominal aortic aneurysm; Angioseal, Angio-seal™(Terumo Interventional Sytems); DTA, Descending thoracic aorta, FA, Femoral artery; F, French; GA, General anesthesia; LA, Local anesthesia; Perclose, ProglidePerclose™ (Abbot Vascular); S.no, Serial Number; SCA, Subclavian artery; TAA, Thoracic aortic aneurysm; VA, Vertebral Artery.

Procedural details of total percutaneous endovascular aorta repair (PEVAR). AAA, Abdominal aortic aneurysm; Angioseal, Angio-seal™(Terumo Interventional Sytems); DTA, Descending thoracic aorta, FA, Femoral artery; F, French; GA, General anesthesia; LA, Local anesthesia; Perclose, ProglidePerclose™ (Abbot Vascular); S.no, Serial Number; SCA, Subclavian artery; TAA, Thoracic aortic aneurysm; VA, Vertebral Artery.

Discussion

EVAR is now the standard of care for TAA, AAA and type B complicated aortic dissection,; however, surgical cut down and closure of access site still remains a concern. Larger wounds, more local site infections, delayed recovery and increased procedural time; along with requirement of a vascular surgeon somehow negated the advantages of EVAR. The total PEVAR on other hand doesn't require a vascular surgeon to be present on site; results in smaller wound with no skin sutures, lesser infections & lesser procedural time without any increase in major complications.,,7, 8, 9 The cost of devices has been a concern; however it is compensated by lesser procedure & anaesthesia time, lesser man hours, lesser complications and length of stay in hospital. VCDs, especially the suture based systems have been used extensively and found safe to close moderate size arteriotomies in various studies and meta-analysis.,,, We share our experience on percutaneous closure of larger arteriotomies where three sites were 22 F, one site was 24 F & two sites were 26 F. We either used three Perclose™ and/or hybrid percutaneous closure technique i.e. combined Perclose™ (which is suture based) & Angio-seal™ (which creates a mechanical seal by sandwiching the arteriotomy between a bioabsorbable anchor and collagen sponge) in closing larger arteriotomies. The data on use of two types of devices to close access sites has been so far rewarding with no higher risk of bleeding or vascular complications., However the maximum size of arteriotomy where the hybrid technique has been tried is 19 F and they have used one Angio-seal™ along with one Perclose™ device. The concern underlying the use of Angio-seal™ with Perclose™ system is acute thrombosis/occlusion of the artery., We successfully used Angio-seal™ along with Perclose™ for closing arteriotomies as large as 26 F and have used Angio-seal™ with three Perclose™ systems to close 04 groins & with two Perclose™ devices to achieve hemostasis in 02 groins. The pulses in all limbs were present post procedure and there was no acute limb ischemia in any of our cases. To conclude: Total PEVAR of thoracic and abdominal aortic pathology is feasible with combined use of 2 different types of VCDs using hybrid technique, even if the arteriotomy is as large as 26 F. We can safely use Angio-seal™ system with more than one Perclose™ devices without compromising the artery.

Declaration of competing interest

All authors have none to declare.
  9 in total

1.  Intentional combination of ProGlide and Angio-Seal for femoral access haemostasis in transcatheter aortic valve replacement.

Authors:  Tsung-Yu Ko; Hsien-Li Kao; Ying-Ju Liu; Chih-Fan Yeh; Ching-Chang Huang; Ying-Hsien Chen; Chi-Sheng Hung; Chih-Yang Chan; Lung-Chun Lin; Yih-Sharng Chen; Mao-Shin Lin
Journal:  Int J Cardiol       Date:  2019-05-23       Impact factor: 4.164

2.  Two-Device Closure Method for Large Diameter Arteriotomies in Percutaneous Endovascular Aortic Repair.

Authors:  Cullen K McCarthy; Feroz Maqbool; Joshua L Gierman
Journal:  Ann Vasc Surg       Date:  2019-08-23       Impact factor: 1.466

3.  A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial).

Authors:  Peter R Nelson; Zvonimir Kracjer; Nikhil Kansal; Vikram Rao; Christian Bianchi; Homayoun Hashemi; Paul Jones; J Michael Bacharach
Journal:  J Vasc Surg       Date:  2014-01-17       Impact factor: 4.268

4.  Femoral incision morbidity following endovascular aortic aneurysm repair.

Authors:  A L Jackson Slappy; Albert G Hakaim; W Andrew Oldenburg; Ricardo Paz-Fumagalli; J Mark McKinney
Journal:  Vasc Endovascular Surg       Date:  2003 Mar-Apr       Impact factor: 1.089

Review 5.  Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair.

Authors:  Madelaine Gimzewska; Alexander Ir Jackson; Su Ern Yeoh; Mike Clarke
Journal:  Cochrane Database Syst Rev       Date:  2017-02-21

6.  Percutaneous repair of aortic aneurysms: a prospective study of suture-mediated closure devices.

Authors:  J Watelet; J-C Gallot; P Thomas; F Douvrin; D Plissonnier
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-04-03       Impact factor: 7.069

7.  Endovascular suture versus cutdown for endovascular aneurysm repair: a prospective randomized pilot study.

Authors:  Giovanni B Torsello; Bernd Kasprzak; Eckhard Klenk; Jörg Tessarek; Nani Osada; Giovanni F Torsello
Journal:  J Vasc Surg       Date:  2003-07       Impact factor: 4.268

8.  Thirty-Day Outcomes after Elective Percutaneous or Open Endovascular Repair of Abdominal Aortic Aneurysms.

Authors:  David S Kauvar; Eric D Martin; Matthew D Givens
Journal:  Ann Vasc Surg       Date:  2015-11-30       Impact factor: 1.466

9.  24h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: An Indian experience.

Authors:  Desabandhu Vinayakumar; Shajudeen Kayakkal; Sandeep Rajasekharan; Julian Johny Thottian; Prasanth Sankaran; Cicy Bastian
Journal:  Indian Heart J       Date:  2016-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.